A Target HbA1c Between 7 and 7.7% Reduces Microvascular and Macrovascular Events in T2D Regardless of Duration of Diabetes: a Meta-Analysis of Randomized Controlled Trials
Crossref DOI link: https://doi.org/10.1007/s13300-021-01062-6
Published Online: 2021-04-24
Published Print: 2021-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sinha, Binayak
Ghosal, Samit http://orcid.org/0000-0002-4141-5187
Text and Data Mining valid from 2021-04-24
Version of Record valid from 2021-04-24
Article History
Received: 16 March 2021
Accepted: 13 April 2021
First Online: 24 April 2021